At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.
Total raised: $2.74M
Funding Rounds 1
Date | Series | Amount | Investors |
17.07.2024 | Grant | $2.74M | - |
Mentions in press and media 3
Date | Title | Description |
18.07.2024 | JaxBio Technologies Pioneering a New Era in Cancer Diagnosis with Cutting-Edge Blood Test Innovation | JaxBio Technologies, a forward-thinking medical diagnostics company headquartered in Netanya, Israel, has recently secured a significant €2.5 million grant from the prestigious European Innovation Council (EIC) Accelerator. This grant marks... |
17.07.2024 | JaxBio Technologies Secures €2.5M Grant from European Innovation Council Accelerator | JaxBio Technologies, a Netanya, Israel-based medical diagnostics company, received a €2.5M grant from the European Innovation Council (EIC) Accelerator. This grant included the option for future blended financing, with a potential additiona... |
16.07.2024 | Medical Diagnostics Company, JaxBio Technologies, Secures €2.5 Million Grant from European Innovation Council Accelerator | Harnessing its cutting-edge liquid biopsy technology, JaxBio is developing a simple blood test for fast, affordable and highly sensitive diagnosis of cancer and other diseases. Funding to Accelerate Development of its Advanced Diagnostics P... |